ES / EN
- January 26, 2021 -
No Result
View All Result
OnCubaNews Needs You
OnCubaNews
  • World
  • Cuba
  • Cuba-USA
  • Opinion
    • Columns
    • Infographic
  • Culture
    • Billboard
  • Sports
  • Styles / Trends
  • Media
  • Special
  • Cuban Flavors
  • World
  • Cuba
  • Cuba-USA
  • Opinion
    • Columns
    • Infographic
  • Culture
    • Billboard
  • Sports
  • Styles / Trends
  • Media
  • Special
  • Cuban Flavors
OnCubaNews
ES / EN
ADVERTISEMENT
Home World USA

United States: Remdesivir treatment to cost 2,340 dollars

The price was quickly criticized. A group of consumers considered it “outrageous” due to the amount that taxpayers invested in the development of the drug

The Associated Press / APbyThe Associated Press / AP
June 29, 2020
in USA
0
Headquarters of the pharmaceutical company Gilead Sciences, in Foster City, California. The company developed the Remdesivir treatment to treat the coronavirus. Photo: Ben Margot, AP

Headquarters of the pharmaceutical company Gilead Sciences, in Foster City, California. The company developed the Remdesivir treatment to treat the coronavirus. Photo: Ben Margot, AP

Help us keep OnCuba alive here

The drug that shortens recovery time in COVID-19 patients will cost 2,340 dollars per treatment for people with health insurance in the United States and other developed countries, the manufacturer reported this Monday.

Gilead Sciences announced that Remdesivir will cost 3,120 dollars for patients with private insurance. What patients pay will depend on their insurance, income, and other factors.

We announced the price today for our investigational antiviral for the treatment of COVID-19. We believe our unique approach will provide broad and equitable access. Read more from our Chairman & CEO: https://t.co/rrEbrDxrLk. pic.twitter.com/9ElSExqSU3

— Gilead Sciences (@GileadSciences) June 29, 2020

“We are in uncharted territory with the price of a new medicine in a pandemic,” Gilead chief executive Dan O’Day told The Associated Press.

“We had to really deviate from normal circumstances” and put a price on the drug to ensure wide access rather than just based on value for patients, he said.

Related Posts

Archive photo, dated October 30, 2015. The then United States Undersecretary of Homeland Security, Cuban-American Alejandro Mayorkas, in the Historic Center of Havana. Photo: Roberto Morejón/EFE Archive

For the first time a Cuban-American at the head of the Department of Homeland Security

November 24, 2020
A supporter of President Trump waves a flag in front of a group of Joe Biden supporters outside an electoral counting center in Philadelphia. Photo: Mario Cruz/EFE

Lessons from the current political situation in the United States

November 19, 2020
Marco Rubio claimed on Saturday, November 7, that an elected president cannot be proclaimed without finishing the counting of all the votes. | CNN

Political action committee created to remove Marco Rubio from the Senate in 2022

November 10, 2020
Rudy Giuliani. Photo: Chris McGrath/Getty Images.

The lawsuits of Trump and his lawyers in courts

November 10, 2020

However, the price was quickly criticized. A group of consumers considered it “outrageous” due to the amount that taxpayers invested in the development of the drug.

The treatments the company donated to the United States and other countries will run out in about a week, and prices will be applied after that, O’Day said.

In 127 poor or middle-income countries, Gilead allows generic manufacturers to supply the drug; two countries already do it at a cost of about 600 dollars per treatment.

The price of Remdesivir had already been anticipated since it became the first drug to show results for the coronavirus, which has killed more than half a million people worldwide in six months.

Descubren posible talón de Aquiles del nuevo coronavirus

The drug interferes with the coronavirus’s ability to copy its genetic material. In a study led by the U.S. government, Remdesivir shortened recovery time by 31%: 11 days on average compared to 15 days for those who receive usual treatment. What has not improved is survival, according to preliminary results after two weeks of follow-up. Results are expected for four weeks.

Gilead says he will have spent 1 billion dollars developing and manufacturing the drug by the end of this year.

The drug is authorized for emergency use in the United States, and Gilead has requested full approval.

Help us keep OnCuba alive here

Tags: coronavirus in the U.SRemdesivir
Previous Post

Japan includes Cuba among countries with migration ban due to pandemic

Next Post

Cuba with one infection by COVID-19 today, there were no deaths

The Associated Press / AP

The Associated Press / AP

Next Post
Today 101 patients were hospitalized for epidemiological clinical surveillance and 85 were under primary healthcare surveillance in their homes. Photo: Ernesto Mastrascusa/EFE

Cuba with one infection by COVID-19 today, there were no deaths

Damage caused by a tornado in the city of Palma Soriano, in eastern Cuba, on June 28, 2020. Photo: Radio Baraguá / Facebook.

Tornado collapses building and causes damages to homes in eastern Cuba

Photo: Radio Habana Cuba

Under the tip of the iceberg

Leave a Reply Cancel reply

The conversation here is moderated according to OnCuba News discussion guidelines. Please read the Comment Policy before joining the discussion.

Your email address will not be published. Required fields are marked *

ADVERTISEMENT

Most Read

Photo: Yamil Lage/EFE/POOL.

Coronavirus: Cuba will produce 100 million doses of its Soberana 02 vaccine

January 21, 2021
Women workers offer disinfectant gel to tourists upon arrival at a hotel, on December 2, 2020, in Cayo Coco. Photo: EFE/Ernesto Mastrascusa/Archive.

Cuba updates COVID-19 health protocol for tourists

January 18, 2021
Photo: CIGBCuba/Twitter.

Cuban COVID-19 nasal vaccine concludes first phase of trials

January 19, 2021
People at a bus stop during the outbreak of COVID-19 in Havana, in January 2021. Photo: Otmaro Rodríguez.

COVID-19 in Cuba: 637 positive cases reported, 324 just in Havana

January 24, 2021

Most Commented

No Content Available
  • About us
  • Work with OnCuba
  • Terms of use
  • Privacy Policy
  • Moderation policy for comments
  • Contact us
  • Advertisement offers

OnCuba and the OnCuba logo are registered® trademarks of Fuego Enterprises, Inc., its subsidiaries or divisions.
OnCuba © by Fuego Enterprises, Inc. All Rights Reserved.

No Result
View All Result
  • World
  • Cuba
  • Cuba-USA
  • Opinion
    • Columns
    • Infographic
  • Culture
    • Billboard
  • Sports
  • Styles / Trends
  • Media
  • Special
  • Cuban Flavors

OnCuba and the OnCuba logo are registered® trademarks of Fuego Enterprises, Inc., its subsidiaries or divisions.
OnCuba © by Fuego Enterprises, Inc. All Rights Reserved.

Do NOT follow this link or you will be banned from the site!
Go to mobile version